These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38134043)
21. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids. Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383 [TBL] [Abstract][Full Text] [Related]
22. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics. Rahimy MH; Cromie MA; Hopkins NK; Tong DM Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166 [TBL] [Abstract][Full Text] [Related]
23. Return of fertility in women discontinuing injectable contraceptives. Fotherby K; Howard G J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276 [TBL] [Abstract][Full Text] [Related]
24. Statement on injectable contraception. International Planned Parenthood Federation IPPF IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511 [TBL] [Abstract][Full Text] [Related]
25. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Jeppsson S; Gershagen S; Johansson ED; Rannevik G Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995 [TBL] [Abstract][Full Text] [Related]
26. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out. Hapgood JP AIDS Res Hum Retroviruses; 2020 May; 36(5):357-366. PubMed ID: 31797677 [TBL] [Abstract][Full Text] [Related]
27. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis. Hapgood JP; Ray RM; Govender Y; Avenant C; Tomasicchio M Am J Reprod Immunol; 2014 Jun; 71(6):505-12. PubMed ID: 24547700 [TBL] [Abstract][Full Text] [Related]
29. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869 [TBL] [Abstract][Full Text] [Related]
30. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives. Fraser IS Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212 [TBL] [Abstract][Full Text] [Related]
31. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488 [TBL] [Abstract][Full Text] [Related]
32. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users. Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367 [TBL] [Abstract][Full Text] [Related]